Splice Bio SPLICE BIO Developing Next Generation Gene Therapies Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that [...]

Origo Biopharma Origo Biopharma, S.L. Innovative small molecules to treat the immune system Origo is a biotech company developing a new generation of therapeutic products for the treatment of several diseases linked to TGF-β in gastrointestinal and lung indications. Founded by biotech/pharma executives from Palobiopharma [...]

Ona Therapeutics Ona Therapeutics, S.L. Novel target to treat metastatic cancer. Spin off from IRB Barcelona based on the research conducted by Dr. Aznar-Benitah in the field of lipid metabolism. Developing a drug targeting metastasis-initiating cells for the treatment of metastatic cancer, a clear unmet [...]